KNTC1 functions as a potential biomarker and oncogene regulating proliferation, migration and apoptosis in gastric cancer
- 2 October 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 143 (Pt 1) , 113257
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- The role of KNTC1 in the regulation of proliferation, migration and tumorigenesis in colorectal cancerCellular Signalling, 2023
- The evolving tumor microenvironment: From cancer initiation to metastatic outgrowthCancer Cell, 2023
- Silencing of KNTC1 inhibits hepatocellular carcinoma cells progression via suppressing PI3K/Akt pathwayCellular Signalling, 2022
- Characteristics of gastric cancer around the worldCritical Reviews in Oncology/Hematology, 2022
- KNTC1 as a putative tumor oncogene in pancreatic cancerJournal of Cancer Research and Clinical Oncology, 2022
- Gastric cancer: a comprehensive review of current and future treatment strategiesCancer and Metastasis Reviews, 2020
- Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancerMedical Oncology, 2020
- CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosisCancer Medicine, 2019
- Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysisJournal of Cellular Biochemistry, 2018
- Bioinformatics Approaches to Predict Drug Responses from Genomic Sequencing2018